A Clinical Trial to Evaluate the Effects of Broc Shot Capsules on Skin Appearance and Comfort in Adults With Reactive, Blemish-Prone, or Hormonally Affected Skin
This is a randomized, double-blind, placebo-controlled, fully decentralized (remote) clinical trial evaluating the effects of Broc Shot Capsules on skin appearance and comfort in adults with reactive, blemish-prone, or hormonally affected skin. Fifty participants aged 18-65 years will be randomly assigned in a 1:1 ratio to receive either Broc Shot Capsules (active) or matched placebo capsules for 8 weeks.
Participants will take 2 capsules once daily and complete self-reported questionnaires and standardized self-captured skin photographs at Baseline, Week 4, and Week 8 via a secure online study platform. Expert dermatologist grading of photographs will be conducted remotely at each timepoint. The study is designed to substantiate consumer product claims related to visible skin improvement and participant-reported skin comfort, and is not intended to evaluate treatment of any clinical dermatological disease.
Přehled studie
Postavení
Postavení
Podmínky
Podmínky
Intervence / Léčba
Intervence / Léčba
Typ studie
Typ studie
Zápis (Odhadovaný)
Zápis
Fáze
Fáze
- Nelze použít
Kontakty a umístění
Studijní kontakt
Studijní kontakt
- Jméno: Gracia Walker
- E-mail: gracia@brocshot.com
Studijní místa
-
-
Nevada
-
Las Vegas, Nevada, Spojené státy, 89101
- Citruslabs
-
-
Kritéria účasti
Kritéria způsobilosti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
- Adults aged 18 to 65 years (inclusive) at the time of consent.
- Self-reported skin concerns matching at least one of the following descriptions: I have red, itchy skin patches
- I have dry, flaky/scaley skin patches
- my skin has blemishes such as pimples, discoloured papules (small, tender bumps that are pink/red/purple/or darker than your natural skin tone) or pustules (a distinct white or yellow pus-filled center surrounded by a red base).
- Generally healthy adults who are willing and able to follow the study protocol for the full 8-week duration, including taking 2 capsules of the study product once daily for 8 consecutive weeks without skipping days, answering questionnaires at Baseline, Week 4, and Week 8, and following the photograph submission protocol at Baseline, Week 4, and Week 8.
- Willing to avoid initiating any new topical or oral skincare products, prescription medications targeting skin, or other dietary supplements specifically marketed for skin benefit during the study period.
- Participants currently using such products who have been using them consistently for at least 3 months prior to enrollment and are willing to continue unchanged throughout the study are eligible.
- Willing to maintain their current diet, lifestyle, sleep pattern, sun exposure habits, and skincare routine for the duration of the trial.
- Resides within the United States.
- Access to a smartphone or computer with internet connection and the ability to use the Citruslabs digital study platform.
Exclusion Criteria:
- Known allergy, hypersensitivity, or intolerance to broccoli, horseradish, other cruciferous vegetables (Brassicaceae family), or any component of the study product or placebo capsule.
- Currently pregnant, breastfeeding, or planning to become pregnant during the study period.
- Currently taking prescription anticoagulant medications (e.g., warfarin, apixaban, rivaroxaban) due to the potential for product ingredients to interact with anticoagulant activity.
- History of a severe or unstable medical condition that, in the opinion of the study team, would prevent safe participation or adherence to the protocol, including active cancer treatment.
- Currently using any oral, topical, or biologic prescription medication specifically indicated for a diagnosed dermatological condition, unless the regimen has been stable for at least 3 months and no changes are planned during the study period.
- Planned dermatological procedures during the study period (e.g., chemical peels, laser treatments, microneedling, injectable cosmetic procedures) that could confound skin appearance assessments.
- Currently enrolled in another clinical or consumer research study, or plans to enroll in any such study during the 8-week study period.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Dvojnásobek
Počet zbraní
Zbraně a zásahy
Skupina účastníků / ArmSkupina účastníků / Arm |
Intervence / LéčbaIntervence / Léčba |
|---|---|
|
Komparátor placeba: Komparátor placeba
|
Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids. |
|
Experimentální: BrocShot Collagen
|
Participants will take 2 capsules once daily, with their first meal of the day, avoiding administration with hot or acidic liquids. |
Co je měření studie?
Primární výstupní opatření
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Clinician-Assessed Change in Overall Skin Appearance
Časové okno: Baseline to Week 8
|
Change from Baseline in overall skin appearance graded by a qualified dermatologist reviewing participant-submitted digital photographs using a binary Yes/No improvement scale assessing overall skin health, pigmentation, dryness, brightness, scarring, blemishes, redness, and flaking |
Baseline to Week 8
|
Sekundární výstupní opatření
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Participant-Reported Change in Skin Appearance
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin appearance assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Clarity
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin clarity assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Calmness
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin calmness assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Visible Skin Concerns
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported visible skin concerns assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Texture
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin texture assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Luminosity
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin luminosity assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Age Appearance
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin age appearance assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Itching and Irritation
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported itching and irritation assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Comfort
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin comfort assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
|
Participant-Reported Change in Skin Confidence
Časové okno: Baseline, Week 4, and Week 8
|
Change from Baseline in self-reported skin confidence assessed via a participant-reported skin questionnaire |
Baseline, Week 4, and Week 8
|
Spolupracovníci a vyšetřovatelé
Sponzor
Sponzor
Spolupracovníci
Spolupracovníci
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Odhadovaný)
Začátek studia
Primární dokončení (Odhadovaný)
Primární dokončení
Dokončení studie (Odhadovaný)
Dokončení studie
Termíny zápisu do studia
První předloženo
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
První zveřejněno
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Poslední zveřejněná aktualizace
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
Další identifikační čísla studie
- BROCS-84181
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .